Page 17 - BH-2-4
P. 17

Brain & Heart                                                          Cardiac sarcoidosis with AVB and VA



               aged adults. J Cardiovasc Electrophysiol. 2014;25:875-881.     doi: 10.1186/s12872-019-01323-0
               doi: 10.1111/jce.12401                          23.  Cacoub  P,  Chapelon-Abric  C,  Resche-Rigon  M,
                                                                  Saadoun D, Desbois AC, Biard L. Cardiac sarcoidosis:
            12.  Kandolin R, Lehtonen J, Kupari M. Cardiac sarcoidosis and
               giant cell myocarditis as causes of atrioventricular block in   A long term follow up study. PLoS One. 2020;15:e0238391.
               young and middle-aged adults. Circ Arrhythm Electrophysiol.      doi: 10.1371/journal.pone.0238391
               2011;4:303-309.
                                                               24.  Kaida T, Inomata T, Minami Y, et al. Importance of early
               doi: 10.1161/CIRCEP.110.959254                     diagnosis of cardiac sarcoidosis in patients with complete
            13.  Terasaki  F,  Azuma  A,  Anzai  T,  et al.  JCS  2016  guideline   atrioventricular block. Int Heart J. 2018;59:772-778.
               on diagnosis and treatment of cardiac sarcoidosis-digest      doi: 10.1536/ihj.17-492
               version. Circ J. 2019;83(11):2329-2388.
                                                               25.  Ekström  K,  Räisänen-Sokolowski  A,  Lehtonen  J,
               doi: 10.1253/circj.cj-19-0508                      Nordenswan HK, Mäyränpää MI, Kupari M. Idiopathic giant
            14.  Judson MA, Costabel U, Drent M,  et al. The WASOG   cell myocarditis or cardiac sarcoidosis? A retrospective audit
               sarcoidosis organ assessment instrument: An update of   of a nationwide case series. ESC Heart Fail. 2020;3:1362-1370.
               a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis.      doi: 10.1002/ehf2.12725
               2014;18:19-27.
                                                               26.  Divakaran S, Stewart GC, Lakdawala NK, et al. Diagnostic
            15.  Birnie DH, Sauer WH, Bogun F, et al. HRS expert consensus   accuracy of advanced imaging in cardiac sarcoidosis. Circ
               statement on the diagnosis and management of arrhythmias   Cardiovasc Imaging. 2020;12(6):e008975.
               associated with cardiac sarcoidosis.  Heart Rhythm.
               2014;7:1304-1323.                                  doi: 10.1161/circimaging.118.008975
               doi: 10.1016/j.hrthm.2014.03.043                27.  Okafor J, Khattar R, Kouranos V,  et  al. Role of serial
                                                                  18 F-fludeoxyglucose positron emission tomography in
            16.  Lee  S,  Birnie  D, Dwivedi  G. Current perspectives on   determining the therapeutic efficacy of immunosuppression
               the immunopathogenesis of sarcoidosis.  Respir Med.   and clinical outcome in patients with cardiac sarcoidosis.
               2020;173:106161.                                   J Nucl Cardiol. 2024;35:101842.
               doi: 10.1016/j.rmed.2020.106161                    doi: 10.1016/j.nuclcard.2024.101842
            17.  Williams O, Fatima S.  Granuloma. Treasure Island, FL:   28.  Zhou Y, Lower EE, Li HP, Costea A, Attari M, Baughman  RP.
               StatPearls Publishing; 2022. Available from: https://www.  Cardiac sarcoidosis: The impact of age and implanted
               ncbi.nlm.nih.gov/books/NBK554586 [Last accessed on   devices on survival. Chest. 2017;151:139-148.
               2024 Jan 27].
                                                                  doi: 10.1016/j.chest.2016.08.1457
            18.  Okada  DR,  Smith  J,  Derakhshan  A,  et al.  Ventricular
               arrhythmias  in  cardiac  sarcoidosis.  Circulation.   29.  Yodogawa K, Fukushima Y, Tachi M,  et al. Localization
               2018;138:1253-1264.                                of late gadolinium enhancement and its association with
                                                                  ventricular tachycardia in patients with cardiac sarcoidosis.
               doi: 10.1161/CIRCULATIONAHA.118.034687             Int Heart J. 2022;63:235-240.
            19.  Lehtonen J, Uusitalo V, Pöyhönen P, Mäyränpää MI,      doi: 10.1536/ihj.21-635
               Kupari  M.  Cardiac  sarcoidosis:  Phenotypes,  diagnosis,
               treatment, and prognosis. Eur Heart J. 2023;44:1495-1510.  30.  Crouser ED, Ono C, Tran T, He X, Raman SV. Improved
                                                                  detection of cardiac sarcoidosis using magnetic resonance
               doi: 10.1093/eurheartj/ehad067                     with myocardial T2 mapping. Am J Respir Crit Care Med.
            20.  Birnie  DH,  Nery  PB,  Ha  AC,  Beanlands  RSB.  Cardiac   2014;189(1):109-112.
               sarcoidosis. J Am Coll Cardiol. 2016;68:411-421.     doi: 10.1164/rccm.201309-1668LE
               doi: 10.1016/j.jacc.2016.03.605                 31.  Cheng RK, Kittleson MM, Beavers CJ, et al. Diagnosis and
            21.  Kakizaki R, Koitabashi T, Minami Y, et al. Untreated cardiac   management of cardiac sarcoidosis: A scientific statement
               sarcoidosis with active inflammation: Severe left ventricular   from the American Heart Association.  Circulation.
               dysfunction and ventricular wall thinning in three years.   2024;149(21):e1197-e1216.
               J Cardiol Cases. 2017;16:141-143.
                                                                  doi: 10.1161/cir.0000000000001240
               doi: 10.1016/j.jccase.2017.06.006
                                                               32.  Kato Y, Morimoto S, Uemura A, Hiramitsu S, Ito T, Hishida H.
            22.  Di Stefano C, Bruno G, Arciniegas Calle MC, et al. Diagnostic   Efficacy of corticosteroids  in sarcoidosis presenting with
               and predictive value of speckle tracking echocardiography   atrioventricular block.  Sarcoidosis Vasc Diffuse Lung Dis.
               in cardiac sarcoidosis. BMC Cardiovascr Disord. 2020;20:21.  2003;20:133-137.



            Volume 2 Issue 4 (2024)                         11                               doi: 10.36922/bh.3515
   12   13   14   15   16   17   18   19   20   21   22